1. Home
  2. DXCM vs ABEV Comparison

DXCM vs ABEV Comparison

Compare DXCM & ABEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • ABEV
  • Stock Information
  • Founded
  • DXCM 1999
  • ABEV 1885
  • Country
  • DXCM United States
  • ABEV Brazil
  • Employees
  • DXCM N/A
  • ABEV N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • ABEV Beverages (Production/Distribution)
  • Sector
  • DXCM Health Care
  • ABEV Consumer Staples
  • Exchange
  • DXCM Nasdaq
  • ABEV Nasdaq
  • Market Cap
  • DXCM 31.7B
  • ABEV 34.8B
  • IPO Year
  • DXCM 2005
  • ABEV N/A
  • Fundamental
  • Price
  • DXCM $75.51
  • ABEV $2.29
  • Analyst Decision
  • DXCM Strong Buy
  • ABEV Hold
  • Analyst Count
  • DXCM 19
  • ABEV 4
  • Target Price
  • DXCM $99.89
  • ABEV $2.35
  • AVG Volume (30 Days)
  • DXCM 4.1M
  • ABEV 31.4M
  • Earning Date
  • DXCM 10-23-2025
  • ABEV 10-30-2025
  • Dividend Yield
  • DXCM N/A
  • ABEV 7.52%
  • EPS Growth
  • DXCM N/A
  • ABEV 2.96
  • EPS
  • DXCM 1.43
  • ABEV 0.17
  • Revenue
  • DXCM $4,300,800,000.00
  • ABEV $16,833,014,419.00
  • Revenue This Year
  • DXCM $17.03
  • ABEV $7.18
  • Revenue Next Year
  • DXCM $15.59
  • ABEV $5.29
  • P/E Ratio
  • DXCM $53.14
  • ABEV $13.33
  • Revenue Growth
  • DXCM 9.30
  • ABEV 13.76
  • 52 Week Low
  • DXCM $57.52
  • ABEV $1.76
  • 52 Week High
  • DXCM $93.25
  • ABEV $2.64
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 41.06
  • ABEV 56.03
  • Support Level
  • DXCM $75.56
  • ABEV $2.17
  • Resistance Level
  • DXCM $81.64
  • ABEV $2.30
  • Average True Range (ATR)
  • DXCM 2.45
  • ABEV 0.04
  • MACD
  • DXCM -0.04
  • ABEV 0.02
  • Stochastic Oscillator
  • DXCM 24.23
  • ABEV 89.47

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

Share on Social Networks: